Facial aging after GLP-1 receptor agonist–induced weight loss: the emerging Ozempic face phenomenon
Journal of Diabetes & Metabolic Disorders · 06.11.2025 · 24 (2)
DOI: 10.1007/s40200-025-01778-3 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Diabetes & Metabolic Disorders, online erschienen am 06.11.2025. Verfasst von Salih Kılıç. Beteiligte Einrichtung: Department of Plastic, Reconstructive and Aesthetic Surgery, Faculty of Medicine, Balıkesir University, Balıkesir, Turkey. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Plastic, Reconstructive and Aesthetic Surgery, Faculty of Medicine, Balıkesir University, Balıkesir, Turkey.
ORCID-Profile: Salih Kılıç
Zitieren
APA
Kılıç, S. (2025). Facial aging after GLP-1 receptor agonist–induced weight loss: the emerging Ozempic face phenomenon. Journal of Diabetes & Metabolic Disorders, 24(2). https://doi.org/10.1007/s40200-025-01778-3
Vancouver
Kılıç S. Facial aging after GLP-1 receptor agonist–induced weight loss: the emerging Ozempic face phenomenon. Journal of Diabetes & Metabolic Disorders. 2025;24(2). doi:10.1007/s40200-025-01778-3
BibTeX
@article{Kl2025,
author = {Kılıç, Salih},
title = {Facial aging after GLP-1 receptor agonist–induced weight loss: the emerging Ozempic face phenomenon},
journal = {Journal of Diabetes & Metabolic Disorders},
year = {2025},
volume = {24},
number = {2},
doi = {10.1007/s40200-025-01778-3}
}
EUVIMED